ICON PLC (ICLR) Actualités

ICON Reports Third Quarter 2024 Results

Highlights Net business wins in the quarter of $2,328 million. Reflects a net book to bill in the quarter of 1.15, and a trailing twelve month...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

ICON plc Schedules Third Quarter 2024 Earnings Conference Call

ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that it will release its...

ICON Survey Highlights Scale of Focus on Precision Therapies in Increasingly Complex Oncology Landscape

Collaboration with industry partners critical to support effective translation of new therapeutic approaches to the clinic ICON plc, (NASDAQ:...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

ICON plc to Present at the Baird 2024 Global Healthcare Conference

ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that Dr. Steve Cutler, CEO...

Form 144 - Report of proposed sale of securities

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

ICON Announces Appointment of New Chief Financial Officer

ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organisation, today announced the appointment of Nigel...

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

ICON Reports Second Quarter 2024 Results

Highlights Net business wins in the quarter of $2,579 million, an increase of 6.6% on quarter two 2023. Reflects a net book to bill in the...